You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Systemic Intravenous Chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Resectable Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Esophageal arterial infusion chemo, Systemic intravenous

Not yet recruiting
  • Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
  • Esophageal arterial infusion chemotherapy
  • Systemic intravenous chemotherapy
  • (no location specified)
May 15, 2022

Intrahepatic Cholangiocarcinoma Trial (Transcatheter arterial chemoembolization, Multi-target Drug Therapy, Immunocheckpoint

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Transcatheter arterial chemoembolization
  • +3 more
  • (no location specified)
Feb 17, 2022

Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)

Recruiting
  • Colorectal Cancer Metastatic
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 3, 2023

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
Has Results
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

Peritoneal Carcinomatosis, Pancreas Tumor Trial in Rome (Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy

Recruiting
  • Peritoneal Carcinomatosis
  • Pancreas Neoplasm
  • Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine
  • Rome, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jan 11, 2023

Cholangiocarcinoma Trial in Navi Mumbai (High Dose Radiation, Systemic chemo)

Recruiting
  • Cholangiocarcinoma
  • High Dose Radiation
  • Systemic chemotherapy
  • Navi Mumbai, Maharashtra, India
    Advanced Centre of Treatment Research and Education In Cancer,Ta
Oct 20, 2022

Ischemic Stroke, Inflammatory Response Trial in Munich (Dornase Alfa, Isotonic Saline Solution)

Not yet recruiting
  • Ischemic Stroke
  • Inflammatory Response
  • Dornase Alfa
  • Isotonic Saline Solution
  • Munich, Bavaria, Germany
    Institute for Stroke and Dementia Research, Ludwig Maximilian Un
Jun 1, 2023

Gastric Adenocarcinoma, Gastric Cancer, Esophagogastric Junction Trial run by the NCI (Paclitaxel, Capecitabine, BardPort

Recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Gastric Cancer, Peritoneal Carcinomatosis Trial in Vilnius (Combined Doxorubicin and Cisplatin Pressurized IntraPeritoneal

Recruiting
  • Gastric Cancer
  • Peritoneal Carcinomatosis
  • Combined Doxorubicin and Cisplatin Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic FOLFOX chemotherapy
  • Vilnius, Vilniaus, Lithuania
  • +1 more
Jan 3, 2023

Low-grade Glioma Trial (DAY101, Chemotherapeutic Agent)

Not yet recruiting
  • Low-grade Glioma
  • (no location specified)
Oct 3, 2022

Postoperative Pain Trial (Systemic nalbuphine, Local nalbuphine)

Not yet recruiting
  • Postoperative Pain
  • Systemic nalbuphine
  • Local nalbuphine
  • (no location specified)
Feb 24, 2022

Gastric Cancer, Peritoneal Metastases Trial in Rotterdam (Irinotecan, CAPOX)

Recruiting
  • Gastric Cancer
  • Peritoneal Metastases
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Jun 15, 2022

Systemic Lupus Erythematosus Trial (Anifrolumab, Placebo)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Anifrolumab
  • Placebo
  • (no location specified)
Apr 18, 2023

Hepatic Metastases, Colon Cancer, Rectal Cancer Trial in United States (Bevacizumab HAI plus systemic chemo, HAI plus systemic

Active, not recruiting
  • Hepatic Metastases
  • +2 more
  • Bevacizumab HAI plus systemic chemotherapy
  • HAI plus systemic chemotherapy
  • Basking Ridge, New Jersey
  • +4 more
Apr 26, 2022

ECMO, Heparin, Respiratory Failure Trial in Dallas (subcutaneous heparin anticoagulation)

Recruiting
  • ECMO
  • +2 more
  • subcutaneous heparin anticoagulation
  • Dallas, Texas
    Baylor Scott & White Health research institute
Jan 25, 2023

NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
  • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
  • Tianjing, Tianjin, China
    Tianjin cancer hospital
Nov 3, 2023

Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial in Montpellier (PIPAC, Cisplatin, Pemetrexed)

Recruiting
  • Peritoneal Mesothelioma
  • Peritoneal Carcinomatosis
  • PIPAC
  • +2 more
  • Montpellier, France
    Institut réginal du Cancer de Montpellier
Nov 3, 2021

Lupus Erythematosus, Systemic Trial in Beijing (low dose GR1603 in phase ?b, high dose GR1603 in phase?b, low dose GR1603 in

Recruiting
  • Lupus Erythematosus, Systemic
  • low dose GR1603 in phase Ⅰb
  • +4 more
  • Beijing, Beijing, China
    Peking union Medical Hosipital
Aug 22, 2023

Breast Cancer, Chemo-induced Nausea and Vomiting Trial in Hanzhou (Aprepitant, Palonosetron, Fosaprepitant)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy-induced Nausea and Vomiting
  • Hanzhou, Zhejiang, China
    the Second Affiliated Hospital of Zhejiang Univercity School of
Apr 23, 2023

Colorectal Cancer, Liver Metastases, Colorectal Adenocarcinoma Trial run by the NCI (device, drug, procedure)

Recruiting
  • Colorectal Cancer
  • +4 more
  • Codman 3000 constant flow pump catheter
  • +8 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2023

BENLYSTA® Special Drug Use Investigation

Recruiting
  • Systemic Lupus Erythematosus
  • Hiroshima, Japan
    GSK Investigational Site
Nov 24, 2022

Gemcitabine, Biliary Tract Cancer, Immune Checkpoint Inhibitors Trial in Hangzhou (Gemcitabine-based chemo regimen combined with

Not yet recruiting
  • Gemcitabine
  • +2 more
  • Gemcitabine-based chemotherapy regimen combined with immunocheckpoint inhibitors
  • Hangzhou, Zhejiang, China
    Hangzhou First People's Hospital
Aug 2, 2022

Postoperative Recovery Trial in Fuzhou (lidocaine, 0.9% saline, Propofol)

Not yet recruiting
  • Postoperative Recovery
  • Fuzhou, Fujian, China
    Fujian provincial hospital
Feb 20, 2023

Toxicity Identified WithSmartphone APPlication Measuring Step

Recruiting
  • Cancer
  • +3 more
    • Leeuwarden, Friesland, Netherlands
    • +2 more
    Jun 28, 2023

    Lung Cancer Stage IV Trial in Kaunas (Bronchoscopic cryotherapy, Pembrolizumab, Platinum based chemo)

    Recruiting
    • Lung Cancer Stage IV
    • Bronchoscopic cryotherapy
    • +2 more
    • Kaunas, Lithuania
      Lithuanian University of Health Sciences
    Aug 16, 2023